US emergency department visits for outpatient adverse drug events, 2013-2014

JAMA - Journal of the American Medical Association

Volumn 316, Issue 20, 2016, Pages 2115-2125

  Shehab, Nadine ^a   Lovegrove, Maribeth C ^a   Geller, Andrew I ^a   Rose, Kathleen O ^b   Weidle, Nina J ^c   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NORTHROP GRUMMAN CORPORATION   (United States)

^c Chenega Government Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BLOOD CLOTTING FACTOR 10A INHIBITOR; CENTRAL STIMULANT AGENT; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; HEPARIN; INSULIN; LINCOSAMIDE; LOW MOLECULAR WEIGHT HEPARIN; MACROLIDE; METRONIDAZOLE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; OXYCODONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEDATIVE AGENT; STEROID; SULFONAMIDE; TETRACYCLINE DERIVATIVE; THROMBIN INHIBITOR; UNINDEXED DRUG; WARFARIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ALLERGIC REACTION; ANXIETY; ARTICLE; BALANCE DISORDER; BLEEDING; CANDIDIASIS; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; DIZZINESS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSARTHRIA; DYSPNEA; EMERGENCY HEALTH SERVICE; EPISTAXIS; FAINTNESS; FATIGUE; FEMALE; GAIT DISORDER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HOSPITALIZATION; HUMAN; HYPERHIDROSIS; HYPOGLYCEMIA; HYPOTENSION; HYPOXIA; LETHARGY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; OUTPATIENT; PRESYNCOPE; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; SEIZURE; SHOCK; SIDE EFFECT; SKIN DISEASE; TREMOR; UNCONSCIOUSNESS; UNITED STATES; UROGENITAL TRACT DISEASE; VERY ELDERLY; WOUND; AGE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEALTH SURVEY; HOSPITAL EMERGENCY SERVICE; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OUTPATIENTS; POPULATION SURVEILLANCE; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 85006086105     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.16201     Document Type: Article

References (42)

1. Schumock GT, Li EC, Suda KJ, et al. National trends in prescription drug expenditures and projections for 2015. Am J Health Syst Pharm. 2015; 72(9):717-736.
2. Institute of Medicine. Preventing Medication Errors. Washington, DC: National Academies Press; 2006.
3. American Geriatrics Society. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-2246.
4. Budnitz DS, Pollock DA,Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296(15):1858-1866.
5. Schroeder T, Ault K. NEISS all injury program. http://www.icpsr.umich.edu/cgi-bin/file?comp =none&study=36280&ds=1&file-id=1194767 &path=ICPSR. Accessed August 16, 2016.
6. US Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch. http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. Accessed August 16, 2016.
7. National Committee for Quality Assurance. HEDIS measures 2015. http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures/HEDIS2015/HEDIS2015NDCLicense/HEDIS2015FinalNDCLists.aspx. Accessed August 16, 2016.
8. Centers for Medicare & Medicaid Services. Physician Quality Reporting System: measure #238 (NQF 0022). https://pqrs.cms.gov/download/c2h5-33fn/application/pdf. Accessed August 16, 2016.
9. US Centers for Disease Control and Prevention. Bridged-race population estimates: 1990-2014. https://wonder.cdc.gov/bridged-race-population.html. Accessed August 16, 2016.
10. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med. 2007;147(11):755-765.
11. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735-743.
12. Linder JA. Antibiotics for treatment of acute respiratory tract infections. Clin Infect Dis. 2008;47 (6):744-746.
13. Frenk SM, Kit BK, Lukacs SL, et al. Trends in the use of prescription antibiotics. J Antimicrob Chemother. 2016;71(1):251-256.
14. US Centers for Disease Control and Prevention. Office-related antibiotic prescribing for persons aged 14 years-United States, 1993-1994 to 2007-2008. JAMA. 2011;306(13):1432-1434.
15. US Centers for Disease Control and Prevention. Get smart: know when antibiotics work. http://www.cdc.gov/getsmart/community/improving-prescribing/interventions/index.html. Accessed August 16, 2016.
16. American Board of Internal Medicine Foundation. Antipsychotics in children and adolescents. http://www.choosingwisely.org/clinician-lists/american-psychiatric-association-antipsychotics-in-children-or-adolescents/. Accessed August 16, 2016.
17. Olfson M, Blanco C, Liu SM, et al. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69(12):1247-1256.
18. Carton L, Cottencin O, Lapeyre-Mestre M, et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals. Curr Pharm Des. 2015;21(23):3280-3297.
19. Rettew DC, Greenblatt J, Kamon J, et al. Antipsychotic medication prescribing in children enrolled in Medicaid. Pediatrics. 2015;135(4):658-665.
20. Centers for Medicare & Medicaid Services. Data show national partnership to improve dementia care exceeds goals to reduce unnecessary antipsychotic medications in nursing homes. https://www.cms.gov/newsroom/MediareleaseDatabase/Fact-sheets/2014-Fact-sheets-items/2014-09-19.html. Accessed August 16, 2016.
21. Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use.AmJ Med. 2015;128(12):1300-5.e2.
22. US Centers for Disease Control and Prevention. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project. MMWR Morb Mortal Wkly Rep. 2005;54(15):380-383.
23. Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy. Chest. 2012;141(2)(suppl):e152S-e184S.
24. Nutescu EA. Anticoagulation management services. Pharmacotherapy. 2010;30(4):327-329.
25. Nutescu EA, Bathija S, Sharp LK, et al. Anticoagulation patient self-monitoring in the United States. Pharmacotherapy. 2011;31(12):1161-1174.
26. US Department of Health and Human Services. National action plan for adverse drug event prevention. https://health.gov/hcq/ade.asp. Accessed August 16, 2016.
27. Centers for Medicare & Medicaid Services. Merit-based incentive payment system and alternative payment model incentive under the physician fee schedule, and criteria for physician-focused payment models. https://www.gpo.gov/fdsys/pkg/FR-2016-05-09/pdf/2016-10032.pdf. Accessed August 16, 2016.
28. Barnes GD, Nallamothu BK, Sales AE, Froehlich JB. Reimagining anticoagulation clinics in the era of direct oral anticoagulants. Circ Cardiovasc Qual Outcomes. 2016;9(2):182-185.
29. Jirón M, Pate V, Hanson LC, et al. Trends in prevalence and determinants of potentially inappropriate prescribing in the United States. J Am Geriatr Soc. 2016;64(4):788-797.
30. American Diabetes Association. 10: Older adults. Diabetes Care. 2016;39(suppl 1):S81-S85.
31. Munshi MN, Florez H, Huang ES, et al. Management of diabetes in long-term care and skilled nursing facilities. Diabetes Care. 2016;39(2): 308-318.
32. Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient. JAMA. 2016;315 (10):1034-1045.
33. Hohl CM, Robitaille C, Lord V, et al. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad Emerg Med. 2005;12 (3):197-205.
34. Roulet L, Ballereau F, Hardouin JB, et al. Adverse drug event nonrecognition in emergency departments. J Emerg Med. 2014;46(6):857-864.
35. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths. MMWR Morb Mortal Wkly Rep. 2016;64(50-51): 1378-1382.
36. AlbertM,McCaig LF, Uddin S. Emergency department visits for drug poisoning. NCHS Data Brief. 2015;196(196):1-8.
37. Leonard CE, Haynes K, Localio AR, et al. Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol. 2008;61(6): 561-571.
38. Lucado J, Paez K, Elixhauser A. Medication-related adverse outcomes in US hospitals and emergency departments. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb109.pdf. Accessed August 16, 2016.
39. Hohl CM, Zed PJ, Brubacher JR, et al. Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann EmergMed. 2010;55(6):493-502.e4.
40. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events. Ann Intern Med. 2004;140 (10):795-801.
41. Agency for Healthcare Research and Quality. Interim data from national efforts to make care safer, 2010-2014. http://www.ahrq.gov/professionals/quality-patient-safety/pfp/interimhacrate2014.html. Accessed August 16, 2016.
42. Agency for Healthcare Research and Quality. Methods to estimate the baseline 2010 PFP national hospital-acquired condition rate. http://www.ahrq.gov/professionals/quality-patient-safety/pfp/index.html#methods. Accessed August 16, 2016.